US Patent 11390922 C-CBL mutations and uses thereof
Patent 11390922 was granted and assigned to University of Chicago on July, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+4 properties)
Infobox
Patent Inventor Names
Ravi Salgia0
Soundarajan Krishnaswamy0
Suvobroto Nandi0
Yi-Hung Carol Tan0
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113909220
Date of Patent
July 19, 2022
0Patent Application Number
159903010
Date Filed
May 25, 2018
0Patent Primary Examiner
Edits on 20 Jul, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
Article (+236 characters)
US Patent 11390922 C-CBL mutations and uses thereof
Article
The present invention relates generally to the fields of molecular biology and growth factor regulation. The invention concerns methods and compositions useful for diagnosing and treating human lung cancer associated with mutated c-CBL.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11390922
Date of patent
July 19, 2022
Patent application number
15990301
Date Filed
May 25, 2018
Patent primary examiner
Find more entities like US Patent 11390922 C-CBL mutations and uses thereof
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.